NMC Royal Hospital forms Patient Advisory Board
- Board is made up of hospital patients, who will participate in review and development of hospital policies, services, and systems
Sunday, March 5 2017. Abu Dhabi: NMC Healthcare, one of the region’s largest private healthcare providers, has committed to maintaining and increasing high standards of care at NMC Royal Hospital Khalifa, City, Abu Dhabi, by introducing a Patient Advisory Board.
The Board, which is made up of existing patients who reside in the hospital’s surrounding community and is headed by the hospital’s management team, aims to identify the service and expectation gaps at the hospital, and represent the voice of the community in regards to patient care.
Commenting on the introduction of the Patient Advisory Board, Dr. B. R. Shetty, Founder and CEO of NMC Healthcare said: “We have always been committed to providing high quality compassionate care to our patients. Now, with the introduction of the Patient Advisory Board, we are excited to take that commitment forward by ensuring our healthcare delivery mechanisms are patient-centric, and quality remain contemporary and thematic.”
The external Board members are hospital patients who have, in the past, proactively shared their experiences and feedback – both positive and not so positive. Their involvement aims to give the hospital’s decision makers a fresh perspective which might otherwise be lost within committees comprising only internal members.
Dr B. R. Shetty continued: “The advisory board is designed to consider both the patient and the patient’s family’s needs in a participative, experiential, and collaborative manner, which will ultimately enhance the patient’s holistic hospital experience.
“The platform will seek information and insights which we will use to empower NMC Royal Hospital on its journey to care excellence. Staff across all levels are committed to working tirelessly to make the Board members an integral part of planning and operations, and in essence, making them the indirect caregivers. We very much look forward to offering a platform explicitly focused on improving outcomes.”
Royal Hospital’s Patient Advisory Board draws inspiration from the UAE Minister of Happiness’s inspiring vision for a thriving society, which is achieved by educating and collaborating with the private sector to put citizen’s happiness at the forefront of its priorities.
Looking ahead, NMC aims to roll the initiative out to its UAE-wide facilities.
About NMC Health
NMC Health plc is the leading private sector healthcare provider based at Abu Dhabi, UAE. The group, having started its operations in the country in 1975, has an international network of hospitals in the UAE, Europe and South America consisting of over forty healthcare facilities across 7 countries, catering to over 12000 patients per day and employing over 1200 doctors looking after 1000 beds.
Clinica Eugin in Spain, Italy, Denmark, Brazil and Columbia, Dr. Sunny Healthcare medical centres in Sharjah, Provita, Americare and Fakih Medical Centers in Abu Dhabi, Dubai and Al Ain, and Al Zahra Hospital at Sharjah were all acquired in the recent past, fortifying NMC’s international reach and comprehensive medical expertise.
NMC Trading, the distribution arm of NMC Healthcare, is a leading supplier of products and consumables across several key market segments of Pharmaceuticals, Medical Equipment and Diagnostics, Medical Consumable and Devices, Veterinary, Personal Care, F & B, Household Care and Home Improvement, and Education with the major contribution coming from the segment of healthcare products. NMC Trading has distribution rights for some of the iconic brands from around the world, including 3M, Medtronic, Welch Allyn, Meyra, Sorg, Patron, Abbott Diabetes Care, Nestle, Unilever, Nivea, Pfizer, Siemens, Samsung, Sanofi, Kiwi, Brylcreem, and Henkel, among others and sells products and services to over 10,000 businesses across the UAE.
In April 2012 NMC Health plc became the first healthcare company from the GCC to list on the London Stock Exchange and is a constituent of the coveted FTSE 250 Index. In 2017, NMC Health plc crossed the $4 billion mark of its market cap value and was valued as a Superbrand for the third consecutive year by the Superbrands Council.